Mice lacking NHERF1 [22–24] and humans harboring mutations or polymorphisms in SLC9A3R1, who are haploinsufficient for NHERF1 [25,26], exhibit hypophosphatemia, osteopenia, and increased fracture rates. Here, NHERF1 is linked to hypophosphatemia.